GE Healthcare’s’ VISIPAQUE has an osmolality equal to that of blood, and is also the only contrast medium formulated with sodium and calcium in a ratio equivalent to blood, according to GE.
The system is FDA approved for use in children over one year of age and is approved for a broad range of diagnostic procedures requiring intravascular contrast, such as coronary angiography, CT, IVP and venography.
April 18, 2024 — Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging ...
April 18, 2024 
April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...
April 05, 2024 
March 29, 2024 — Magnetic resonance imaging (MRI) is a cornerstone in the landscape of medical diagnostics, celebrated ...
March 29, 2024 
March 8, 2024 — Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies ...
March 08, 2024 
February 6, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) held its 2024 SNMMI Mid-Winter Meeting ...
February 06, 2024 
Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in ...
January 17, 2024 
December 11, 2023 — Bracco Imaging S.p.A., an innovative world leader delivering end-to-end products and solutions ...
December 11, 2023 
November 3, 2023 — Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, announced ...
November 03, 2023 
October 17, 2023 — Halo Precision Diagnostics, a leader in early disease detection using precision diagnostics, today ...
October 17, 2023 
September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to ...
September 15, 2023